These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35032570)

  • 1. Preclinical frailty assessments: Phenotype and frailty index identify frailty in different mice and are variably affected by chronic medications.
    Mach J; Allore H; Gnjidic D; Gemikonakli G; Kane AE; Howlett SE; de Cabo R; Le Couteur D; Hilmer SN
    Exp Gerontol; 2022 May; 161():111700. PubMed ID: 35032570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice.
    Mach J; Gemikonakli G; Logan C; Vander Wyk B; Allore H; Ekambareshwar S; Kane AE; Howlett SE; de Cabo R; Le Couteur DG; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1010-1018. PubMed ID: 32147704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study.
    Reallon E; Chavent B; Gervais F; Dauphinot V; Vernaudon J; Krolak-Salmon P; Mouchoux C; Novais T
    Int J Clin Pharm; 2020 Apr; 42(2):508-514. PubMed ID: 32140916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
    O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk prescribing and incidence of frailty among older community-dwelling men.
    Gnjidic D; Hilmer SN; Blyth FM; Naganathan V; Cumming RG; Handelsman DJ; McLachlan AJ; Abernethy DR; Banks E; Le Couteur DG
    Clin Pharmacol Ther; 2012 Mar; 91(3):521-8. PubMed ID: 22297385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication Assessment in an Older Population during Acute Care Hospitalization and Its Effect on the Anticholinergic Burden: A Prospective Cohort Study.
    Espaulella-Ferrer M; Molist-Brunet N; Espaulella-Panicot J; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Otero-Viñas M
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study.
    Alqahtani B
    Front Public Health; 2023; 11():1148671. PubMed ID: 37304087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.
    Veronese N; Stubbs B; Noale M; Solmi M; Pilotto A; Vaona A; Demurtas J; Mueller C; Huntley J; Crepaldi G; Maggi S
    J Am Med Dir Assoc; 2017 Jul; 18(7):624-628. PubMed ID: 28396180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of polypharmacy with frailty severity and each frailty phenotype in community-dwelling older adults: Itabashi Longitudinal Study on Aging.
    Daimaru K; Osuka Y; Kojima N; Mizukami K; Motokawa K; Iwasaki M; Inagaki H; Miyamae F; Okamura T; Hirano H; Awata S; Sasai H
    Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():196-201. PubMed ID: 38169078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians.
    Harris DA; Guo Y; Nakhla N; Tadrous M; Hogan DB; Hennessy D; Langlois K; Garner R; Leslie S; Bronskill SE; Heckman G; Maxwell CJ
    Health Rep; 2022 Jun; 33(6):3-16. PubMed ID: 35876612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing.
    Gemikonakli G; Mach J; Zhang F; Bullock M; Tran T; El-Omar E; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2023 Feb; 78(2):213-222. PubMed ID: 36124741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm.
    Lam JYJ; Barras M; Scott IA; Long D; Shafiee Hanjani L; Falconer N
    Drugs Aging; 2022 May; 39(5):333-353. PubMed ID: 35597861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy at discharge in older hospitalised patients in Vietnam and its association with frailty.
    Nguyen TX; Nguyen TN; Nguyen AT; Nguyen HTT; Nguyen TTH; Nguyen TN; Pham T; Vu HTT
    Australas J Ageing; 2020 Sep; 39(3):230-236. PubMed ID: 31677221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial.
    Jamieson H; Nishtala PS; Bergler HU; Weaver SK; Pickering JW; Ailabouni NJ; Abey-Nesbit R; Gullery C; Deely J; Gee SB; Hilmer SN; Mangin D
    J Gerontol A Biol Sci Med Sci; 2023 Aug; 78(9):1692-1700. PubMed ID: 36692224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy Is Significantly and Positively Associated with the Frailty Status Assessed Using the 5-Item FRAIL Scale, Cardiovascular Health Phenotypic Classification of Frailty Index, and Study of Osteoporotic Fractures Scale.
    Hung CD; Yang CC; Lee CY; Hu SC; Chen SC; Hung CH; Chuang HY; Chen CY; Kuo CH
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy is associated with frailty in Japanese community-dwelling older adults.
    Yuki A; Otsuka R; Tange C; Nishita Y; Tomida M; Ando F; Shimokata H
    Geriatr Gerontol Int; 2018 Oct; 18(10):1497-1500. PubMed ID: 30168240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Changes in Number of Medications and Drug Burden Index Exposure on Transitions Between Frailty States and Death: The Concord Health and Ageing in Men Project Cohort Study.
    Jamsen KM; Bell JS; Hilmer SN; Kirkpatrick CM; Ilomäki J; Le Couteur D; Blyth FM; Handelsman DJ; Waite L; Naganathan V; Cumming RG; Gnjidic D
    J Am Geriatr Soc; 2016 Jan; 64(1):89-95. PubMed ID: 26782856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
    Porter B; Arthur A; Savva GM
    BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Effects of Frailty and Polypharmacy on Health Outcomes in Older Adults: Frailty Outweighs Polypharmacy.
    Chen YZ; Huang ST; Wen YW; Chen LK; Hsiao FY
    J Am Med Dir Assoc; 2021 Mar; 22(3):606.e7-606.e18. PubMed ID: 32873474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frailty prevalence using Frailty Index, associated factors and level of agreement among frailty tools in a cohort of Japanese older adults.
    Arakawa Martins B; Visvanathan R; Barrie H; Huang CH; Matsushita E; Okada K; Satake S; Uno C; Kuzuya M
    Arch Gerontol Geriatr; 2019; 84():103908. PubMed ID: 31319367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.